Company: SABR
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001628280-25-049383
Chunk: 173

Company: Sabre Corp
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 8
Chunk 173
---
holders, basic 48,431 (62,103)(156,009)(199,577)Add: Interest expense and amortization of debt discount and issuance costs for exchangeable notes, net of tax2,526 — — — Net income (loss) from continuing operations available to common stockholders, diluted$50,957 $(62,103)$(156,009)$(199,577)Denominator:Basic weighted-average common shares outstanding394,580 385,729 390,616 383,013 Add: Dilutive effect of stock options and restricted stock awards1,340 — — — Add: Dilutive effect of exchangeable notes33,333 — — — Diluted weighted-average common shares outstanding429,253 385,729 390,616 383,013 Loss per share from continuing operations:Basic$0.12 $(0.16)$(0.40)$(0.52)Diluted$0.12 $(0.16)$(0.40)$(0.52)Basic earnings per share is computed by dividing net income from continuing operations available to common stockholders by the weighted-average number of common shares outstanding during each period. Diluted earnings per share is computed by dividing net income from continuing operations available to common stockholders by the weighted-average number of common shares outstanding plus the effect of all dilutive common stock equivalents during each period. The diluted weighted-average common shares outstanding calculation excludes 4 million of dilutive stock options and restricted stock awards for the nine months ended September 30, 2025, and 3 million and 2 million of dilutive stock options and restricted stock awards for the three and nine months ended September 30, 2024, respectively, as their effect would be anti-dilutive given the net loss incurred in the period. The calculation of diluted weighted-average shares excludes the impact of 8 million and 1 million of anti-dilutive common stock equivalents for the three and nine months ended September 30, 2025, and 1 million and 3 million of anti-dilutive common stock equivalents for the three and nine months ended September 30, 2024, respectively.We have used the if-converted method for calculating any potential dilutive effect of the Exchangeable Notes on our diluted net income per share. Under the if-converted method, the 2025 Exchangeable Notes are assumed to